Apparent Treatment-Resistant Hypertension Common in CKD
Most patients with CKD and apparent treatment-resistant hypertension had uncontrolled resistant hypertension or refractory hypertension.
Urologic Disorders
FDA Approves Terlivaz to Improve Kidney Function in Hepatorenal Syndrome
Terlivaz is a vasopressin analogue selective for V1 receptors.
Tadalafil May Ease Voiding Problems in Women
In a small study, tadalafil, a PDE5 inhibitor used to treated erectile dysfunction, significantly decreased opening urethral pressure in healthy women.
August 2022 Recap: Drug Pipeline Update
Stay up-to-date on the latest drugs in development.
Estimated GFR Dip With Dapagliflozin Not Linked to Higher CKD Progression Risk
Understanding clinical characteristics associated with a decline in eGFR can help guide optimal use of SGLT2 inhibitors in clinical practice, according to investigators.
Diuretic Use Varies Widely in US Hemodialysis Practice
Uncertainty regarding diuretic efficacy and optimal dosing in hemodialysis likely contributes to practice variation, according to investigators.
Inappropriate Antibiotic Prescribing for Uncomplicated Cystitis Still Occurs
Urologists appear more likely than other specialists to inappropriately treat uncomplicated cystitis, according to study findings.
Guideline Addresses Anorectal Abscess; Anal, Rectovaginal Fistulas
Clinical guidelines updated for management of anorectal abscess, fistula-in-ano, and rectovaginal fistula
